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Abstract
Hepatitis E virus (HEV) is one of the leading agents of acute
hepatitis. This study investigated the prevalence and risk factors
of HEV infection in the Tunisian adult general population, either
in blood donors (n = 687) or in patients hospitalized for acute
hepatitis (n = 202). The mode of transmission differed between
these two populations: contact with animals and living in a rural
habitat were the main risk factors for being in contact with HEV
in asymptomatic blood donors, while HEV was contracted
through contaminated water in symptomatic cases. HEV sero-
prevalence in adult blood donors in Tunisia was relatively low
(5.4%) and increased with age.
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Tunisia is considered as an endemic country for HEV [1].
However, in contrast to other North African countries such
as Egypt, Algeria or Morocco [2–4], HEV outbreaks have
never been reported in Tunisia [5]. We evaluated the sero-
prevalence of HEV infection in the Tunisian adult general
population and identiﬁed the risk factors associated with
seropositive cases.
Two distinct adult groups were studied. Participants were
included in the study during September 2007 to June 2008.
Records about age, sex, living conditions and personal and
family medical history were evaluated by reviewing the
patient’s medical chart and by interviewing each patient
through a structured questionnaire. Subjects were asked
about their contact with animals (farming or trade of sheep,
cattle, goats, horses, rabbits and poultry, and hunting of wild
animals) and about their sanitary conditions (use of municipal
water vs. water from other sanitary uncontrolled sources,
and linkage to the municipal drainage). Patients’ sera were
tested for the presence of IgG and IgM anti-HEV (MP Diag-
nostics, Singapore) and IgM anti-HAV (ADVIA Centaur, Sie-
mens, France). Odds ratios (ORs) with 95% conﬁdence
intervals (CIs) were calculated using the Pearson v2 test and
a multiple unconditional logistic regression model.
First we studied blood donors (n = 687), mean age
32.6 ± 8.6 years, originating from the governorates of Tunis
(northern region), Monastir and Mahdia (eastern region).
The main advantage of these areas was the ability to reﬂect
the whole spectrum of sociological behaviours and housing
conditions, from rural to urban, and from low-income high-
density to economically advanced urban areas. The second
group (n = 202) consisted of adults (mean age 39.0 ± 16.0)
hospitalized for acute hepatitis at Charles-Nicolle Hospital,
Tunis. Characteristics of each group and results of the risk
factor analyses are summarized in Tables 1 and 2. Results
did not differ by multivariate analysis for hospitalized patients
(data not shown).
Anti-HEV IgG were detected in 5.4% of the blood donors.
Seroprevalence increased signiﬁcantly with age, from 2.2% of
patients younger than 30 years old to 8.0% of patients older
than 30. In hospitalized patients, no IgM anti-HEV was
detected in patients younger than 30 years old. Seropreva-
lence was 26.7% for IgM anti-HAV, with a mean age of
26.3 ± 6.3 and 3.0% for IgM anti-HEV with a mean age of
41.0 ± 5.9. The age difference was statistically signiﬁcant
(p <10)5, Student’s t-test).
In bivariate analysis, the factors associated with anti-HEV
positivity in blood donors were age, living in rural or in low-
income high-density urban areas, a low level of education,
personal history of hepatitis, poor sanitary conditions and
contact with animals. No difference in the prevalence of IgG
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anti-HEV was observed with respect to sex, region of origin,
number of persons per household or familial history of hepa-
titis. In multiple logistic regression analysis, the remaining
independent risk factors were age, habitat and contact with
animals but not education level or sanitary conditions. In
contrast, the only factor associated with symptomatic hepati-
tis E cases was the consumption of uncontrolled water.
Compared with the two recent age-related studies per-
formed in central Tunisia [6,7], we found a lower prevalence
of hepatitis E. This discrepancy might be attributable to the
difference in the study sample sizes, the region of origin of
the populations studied or the ELISA kits used (Globe Diag-
nostics SRL, Milano, Italy, for the studies by Hannachi et al.).
Indeed the MP Diagnostics’ kit might underestimate the se-
roprevalence linked to genotype 3 strains [8]. However, the
Globe Diagnostics kit was not accurately evaluated on this
genotype.
A higher risk of infection was found in high-density urban
areas compared with standard-density urban areas. However,
neither a large family household nor a familial history of hep-
atitis infections constitute a risk factor, thus indicating a low
risk of person-to-person transmission, as suggested in other
studies [9], but in contrast to what is suggested in Hann-
achi’s study [6]. Population density per se does not seem to
constitute a risk factor. Indeed, in Tunisia, similarly good san-
itary conditions (tap water and link to drainage network) are
found in standard and in densely populated urban areas. The
key differences between inhabitants of densely populated
urban areas and other urban areas are a generally lower eco-
nomic status, with a lower level of education and, for the
majority of them, a previous rural origin. Therefore, in this
population, HEV might have been contracted previously
while living in a rural area.
The low seroprevalence and the age distribution of HEV
in Tunisia do not reﬂect the classical epidemiological proﬁle
described for an endemic country [10]. These ﬁndings are in
agreement with the absence of waterborne epidemics
described in Tunisia, in contrast to other North African
TABLE 1. Blood donors: population characteristics and risk factors associated with IgG anti-HEV positivity
Descriptive analysis Bivariate analysis Multivariate analysis
Risk factor parameter %
IgG anti-HEV
seropositive (%) OR 95% CI OR 95% CI
Male 81.7 5.9 1.91 0.66–5.48
Age > 30 54.3 8.0 3.84 1.66–8.87 3.05 1.27–7.34
Origin: Northern region 54.6 5.3 0.98 0.5–1.91
Habitat
Rural 39.3 9.6 6.22 2.52–15.34 5.24 1.28–21.53
Urban high density, low income 8.9 8.2 5.21 1.54–17.65 4.59 1.31–16.15
Urban economically advanced 51.8 1.7 1
>5 persons per household 35.5 5.3 0.983 0.49–1.97
Education level
Primary school 23.7 9.8 7.11 2.03–24.85 1.12 0.52–2.39
Secondary school 47.3 5.5 3.83 1.11–13.17 0.35 0.10–1.26
High school 29.0 1.5 1
Personal history of hepatitis 11.2 14.9 3.22 1.49–6.50 2.25 0.97–5.19
Family history of hepatitis 16.2 8.8 1.73 0.79–3.77
Contact with animals 19.4 16.7 4.96 2.52–9.75 2.90 1.20–6.98
Municipal + other water 18.2 13.6 3.35 1.68–6.66 1.57 0.71–3.48
No connection to sewage 39.7 9.2 3.38 1.67–6.85 0.56 0.13–2.41
OR, odds ratio; CI, conﬁdence interval.
Bold value indicate statistically signiﬁcant results.
TABLE 2. Acute hepatitis: population characteristics and bivariate analysis of the risk factors associated with IgM anti-HEV or
IgM anti-HAV positivity
IgM anti-HEV seropositive IgM anti-HAV seropositive
Risk factor parameter % % OR 95% CI % OR 95% CI
Male 50.9 4.9 5 0.57–43.58 39.8 4.37 2.16–8.84
Age £ 30 39.6 0.0 0 [0–Na] 56.3 16.14 7.18–36.28
Rural habitat 54.0 3.7 1.73 0.31–9.67 36.7 3.27 1.64–6.51
Personal history of hepatitis 23.8 0.0 0 Na–Inf 18.8 0.56 0.25–1.25
Family history of hepatitis 28.7 6.9 5.26 0.94–29.55 19.0 0.55 0.26–1.16
Contact with animals 33.2 1.5 0.39 0.04–3.41 13.4 0.31 0.14–0.68
Municipal + other water 31.7 7.8 11.61 1.33–101.55 40.6 2.69 1.41–5.15
OR, odds ratio; CI, conﬁdence interval.
Bold value indicate statistically signiﬁcant results.
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countries. Although more than 90% of the Tunisian popula-
tion has already been in contact with HAV at the age of 20
[5], more than a quarter of acute hepatitis infections were
due to HAV and only 3% to HEV. HAV and other enterovi-
ruses but no HEV could be detected in treated wastewater
(A. M. Aouni Mahjoub, unpublished data and [11]), which is
likely to explain these observations. A relatively late acquisi-
tion of HEV compared with HAV suggests a role of what
people are eating rather than contaminated water supplies
only, as is observed in industrialized countries [1]. Thus, hep-
atitis E in Tunisia seemed to be mainly a subclinical, asymp-
tomatic infection caused by contact with animals, as in
developed countries [12]. However, symptomatic infections
appeared to be mainly caused by contaminated water.
Remarkably, waterborne HEVs (genotypes 1 and 2) are
known to be more virulent than strains transmitted through
animals (genotypes 3 and 4) [1,13]. Clinical presentation and
modes of transmission suggest that genotype 1 might not be
the only genotype circulating in Tunisia as previously thought
[1,13]. Our study highlights the need for genotype character-
ization of the Tunisian strains and determination of the
animal reservoir [14]. Indeed, domestic and wild pigs can be
excluded here: pork products are not consumed, live
pigs are not raised in the country and the wild boars present
in some parts of the territory are not endemic in the
two regions studied. Goats in particular are raised in the
proximity of Tunisian people and might be a source of
contamination.
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